Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: A 4-T proton MRS study

American Journal of Psychiatry

Volumn 162, Issue 2, 2005, Pages 394-396

  Rowland, Laura M ^a   Bustillo, Juan R ^b   Mullins, Paul G ^b   Jung, Rex E ^b   Lenroot, Rhoshel ^b   Landgraf, Elma ^b   Barrow, Ranee ^b   Yeo, Ronald ^b   Lauriello, John ^b   Brooks, William M ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMIC ACID; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROTRANSMITTER;

ADULT; ARTICLE; BRAIN FUNCTION; CINGULATE GYRUS; HUMAN; MALE; METABOLISM; NEUROTRANSMITTER RELEASE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTON NUCLEAR MAGNETIC RESONANCE; PSYCHIATRY; SCHIZOPHRENIA; TASK PERFORMANCE;

ADULT; BRIEF PSYCHIATRIC RATING SCALE; CROSS-OVER STUDIES; EXCITATORY AMINO ACID ANTAGONISTS; GLUTAMATES; GYRUS CINGULI; HUMANS; KETAMINE; MAGNETIC RESONANCE SPECTROSCOPY; MALE; NEUROPSYCHOLOGICAL TESTS; PLACEBOS; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIA;

EID: 13444267336     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.162.2.394     Document Type: Article

References (19)

1. Olney JW, Farber NB: Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 1995; 52:998-1007
2. Farber NB, Newcomer JW, Olney JW: The glutamate synapse in neuropsychiatric disorders: focus on schizophrenia and Alzheimer's disease. Prog Brain Res 1998; 116:421-437
3. Moghaddam B, Adams B, Verma A, Daly D: Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 1997; 17:2921-2927
4. Rothman DL, Behar KL, Hyder F, Shulman RG: In vivo NMR studies of the glutamate neurotransmitter flux and neuroenergetics: implications for brain function. Annu Rev Physiol 2003; 65:401-427
5. Kanamori K, Ross BD, Kondrat RW: Glial uptake of neurotransmitter glutamate from the extracellular fluid studied in vivo by microdialysis and (13)C NMR. J Neurochem 2002; 83:682-695
6. First MB, Spitzer RL, Gibbon M, Williams JBW: Structured Clinical Interview for DSM-IV Axis I Disorders - Non-Patient Edition (SCID-I/NP), version 2.0. New York, New York State Psychiatric Institute, Biometrics Research, 1996
7. Newcomer JW, Farber NB, Jevtovic-Todorovic V, Selke G, Melson AK, Hershey T, Craft S, Olney JW: Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis. Neuropsychopharmacology 1999; 20:106-118
8. Bartha R, Drost DJ, Menon RS, Williamson PC: Comparison of the quantification precision of human short echo time (1)H spectroscopy at 1.5 and 4.0 Tesla. Magn Reson Med 2000; 44:185-192
9. Théberge J, Bartha R, Drost DJ, Menon RS, Malla A, Takhar J, Neufeld RW, Rogers J, Pavlosky W, Schaefer B, Densmore M, Al-Semaan Y, Williamson PC: Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers. Am J Psychiatry 2002; 159:1944-1946
10. Théberge J, Al-Semaan Y, Williamson PC, Menon RS, Neufeld RWJ, Rajakumar N, Schaefer B, Densmore M, Drost DJ: Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS. Am J Psychiatry 2003; 160:2231-2233
11. Overall JE, Gorham DR: The Brief Psychiatric Rating Scale. Psychol Rep 1962; 10:799-812
12. Andreasen NC: Modified Scale for the Assessment of Negative Symptoms (SANS). Iowa City, University of Iowa, 1984
13. Bremner JD, Putnam F, Southwick SM, Krystal JH, Hansen C, Roach L, Johnson DR, Charney DS: The Clinician-Administered Dissociative States Scale: studies on reliability and validity in use in the assessment of patients with psychiatric disorders, in 1992 Annual Meeting New Research Program and Abstracts. Washington, DC, American Psychiatric Association, 2003, number 157
14. Lezak MD: Neuropsychological Assessment, 3rd ed. New York, Oxford University Press, 1995
15. Pardo JV, Pardo PJ, Janer KW, Raichle ME: The anterior cingulate cortex mediates processing selection in the Stroop attentional conflict paradigm. Proc Natl Acad Sci USA 1990; 87:256-259
16. 2(15)O demonstrate ketamine actions in CNS dynamically. Neuropsychopharmacology 2001; 25:165-172
17. Vollenweider FX, Leenders KL, Oye I, Hell D, Angst J: Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET). Eur Neuropsychopharmacol 1997; 7:25-38
18. 18F]fluorodeoxyglucose (FDG). Eur Neuropsychopharmacol 1997; 7:9-24
19. Bartha R, Williamson PC, Drost DJ, Malla A, Carr J, Cortese L, Canaran G, Rylett RJ, Neufeld RW: Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy. Arch Gen Psychiatry 1997; 54:959-965